Lung injury after cardiopulmonary bypass: Alternative treatment prospects

被引：0

作者：

Xue-Mei Zheng ^{[1
]}

Zhuo Yang ^{[2
]}

Guang-Li Yang ^{[3
]}

Yan Huang ^{[4
]}

Jie-Ru Peng ^{[5
]}

Meng-Jun Wu ^{[6
]}

机构：

[1] School of Medicine, University of Electronic Science and Technology of China

[2] Department of Pharmacy, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China

[3] Department of Medical Administration, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China

[4] National Institute of Drug Clinical Trial, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China

[5] Department of Medical Records Statistics, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China

[6] Department of Anesthesiology, The Affiliated Hospital, School of Medicine, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology

来源：

World Journal of Clinical Cases | 2022年 / 10卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R563 [肺疾病];

学科分类号：

1002 ; 100201 ;

摘要：

Although the lung injury caused by cardiopulmonary bypass(CPB) has been extensively investigated, the incidence and mortality of lung injury after CPB remain a prominent clinical problem. The poor outcome has been attributed to multifactorial etiology, including the systemic inflammatory response and ischemia reperfusion(I/R) injury during CPB. Lung injury after CPB is a complex pathophysiological process and has many clinical manifestations of mild to severe disease. Which is associated with prognosis. To alleviate this lung injury, interventions that address the pathogenesis are particularly important. This review summarizes the pathogenesis, mechanism and treatment options of lung injury after CPB, such as lung protection with intralipid.

引用

页码：753 / 761

页数：9

共 50 条

[1] Lung injury after cardiopulmonary bypass: Alternative treatment prospects
Zheng, Xue-Mei
Yang, Zhuo
Yang, Guang-Li
Huang, Yan
Peng, Jie-Ru
Wu, Meng-Jun
WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (03) : 753 - 761
[2] Lung injury after cardiopulmonary bypass
Clark, Stephen C.
PERFUSION-UK, 2006, 21 (04): : 225 - 228
[3] Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass
Asimakopoulos, G
Smith, PLC
Ratnatunga, CP
Taylor, KM
ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1107 - 1115
[4] Pulmonary injury after cardiopulmonary bypass
Conti, VR
CHEST, 2001, 119 (01) : 2 - 4
[5] PANCREATIC INJURY AFTER CARDIOPULMONARY BYPASS
OHRI, SK
HASHEMI, M
KEOGH, BE
TAYLOR, KM
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (08): : 573 - 573
[6] Acute lung injury in the setting of cardiopulmonary bypass
Royston, D
DISEASE MARKERS IN EXHALED BREATH: BASIC MECHANISMS AND CLINICAL APPLICATIONS, 2002, 346 : 369 - 374
[7] ALTERNATIVE METHOD OF ULTRAFILTRATION AFTER CARDIOPULMONARY BYPASS
GROOM, RC
AKL, BF
ALBUS, RA
HILL, A
MUNOZ, R
LEFRAK, EA
ANNALS OF THORACIC SURGERY, 1994, 58 (02): : 573 - 574
[8] Effects of pentastarch-deferoxamine conjugate on lung injury after cardiopulmonary bypass
Stamler, A
Wang, SY
Aguirre, DE
Sellke, FW
Johnson, RG
CIRCULATION, 1996, 94 (09) : 358 - 363
[9] Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass
Carney, DE
Lutz, CJ
Picone, AL
Gatto, LA
Ramamurthy, NS
Golub, LM
Simon, SR
Searles, B
Paskanik, A
Snyder, K
Finck, C
Schiller, HJ
Nieman, GF
CIRCULATION, 1999, 100 (04) : 400 - 406
[10] Total liquid ventilation reduces lung injury in piglets after cardiopulmonary bypass
Jiang, Lijun
Wang, Qiang
Liu, Yinglong
Du, Ming
Shen, Xiangdong
Guo, Xiaogang
Wu, Song
ANNALS OF THORACIC SURGERY, 2006, 82 (01): : 124 - 130

← 1 2 3 4 5 →